Literature DB >> 1500508

Standardization of an enzyme immunoassay for human antibody to Haemophilus ducreyi.

M Desjardins1, C E Thompson, L G Filion, J O Ndinya-Achola, F A Plummer, A R Ronald, P Piot, D W Cameron.   

Abstract

We standardized a serologic enzyme immunoassay (EIA) for human immunoglobulin G and M antibodies against Haemophilus ducreyi. We evaluated the performance of this test with respect to the time from acute chancroid and coinfection with human immunodeficiency virus (HIV). Antibody to a crude, soluble bacterial antigen of one H. ducreyi strain was detected in a panel of serum samples from clinically and microbiologically confirmed cases of chancroid and from controls. Test interpretation was standardized for optimal sensitivity and specificity. Performance of the EIA was enhanced in the period of early convalescence from acute primary chancroid and was not diminished in the presence of HIV coinfection. The EIA performed adequately as a serologic screening test for field evaluation and epidemiologic application in conjunction with sexually transmitted disease and HIV detection and control efforts.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1500508      PMCID: PMC265434          DOI: 10.1128/jcm.30.8.2019-2024.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  Basic principles of ROC analysis.

Authors:  C E Metz
Journal:  Semin Nucl Med       Date:  1978-10       Impact factor: 4.446

2.  Receiver operator characteristic (ROC) curves.

Authors:  M D Nettleman
Journal:  Infect Control Hosp Epidemiol       Date:  1988-08       Impact factor: 3.254

3.  Monoclonal antibodies reactive with all strains of Haemophilus ducreyi.

Authors:  E J Hansen; T A Loftus
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

4.  The meaning and use of the area under a receiver operating characteristic (ROC) curve.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1982-04       Impact factor: 11.105

Review 5.  Chancroid and the role of genital ulcer disease in the spread of human retroviruses.

Authors:  P G Jessamine; A R Ronald
Journal:  Med Clin North Am       Date:  1990-11       Impact factor: 5.456

6.  The clinical diagnosis of genital ulcer disease in men in the tropics.

Authors:  M V Fast; L J D'Costa; H Nsanze; P Piot; J Curran; P Karasira; N Mirza; I W Maclean; A R Ronald
Journal:  Sex Transm Dis       Date:  1984 Apr-Jun       Impact factor: 2.830

7.  Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men.

Authors:  K L Huang; F L Ruben; C R Rinaldo; L Kingsley; D W Lyter; M Ho
Journal:  JAMA       Date:  1987-04-17       Impact factor: 56.272

8.  Use of an enzyme immunoassay to detect serum IgG antibodies to Haemophilus ducreyi.

Authors:  K Museyi; E Van Dyck; T Vervoort; D Taylor; C Hoge; P Piot
Journal:  J Infect Dis       Date:  1988-05       Impact factor: 5.226

9.  Laboratory diagnosis of Haemophilus ducreyi: sensitivity of culture media.

Authors:  J Dylewski; H Nsanze; G Maitha; A Ronald
Journal:  Diagn Microbiol Infect Dis       Date:  1986-03       Impact factor: 2.803

Review 10.  Biology of Haemophilus ducreyi.

Authors:  W L Albritton
Journal:  Microbiol Rev       Date:  1989-12
View more
  13 in total

1.  Development of a serological test for Haemophilus ducreyi for seroprevalence studies.

Authors:  C Elkins; K Yi; B Olsen; C Thomas; K Thomas; S Morse
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

Review 2.  Diagnostic tests for chancroid.

Authors:  D A Lewis
Journal:  Sex Transm Infect       Date:  2000-04       Impact factor: 3.519

Review 3.  Randomised trials of STD treatment for HIV prevention: report of an international workshop. HIV/STD Trials Workshop Group.

Authors:  R Hayes; M Wawer; R Gray; J Whitworth; H Grosskurth; D Mabey
Journal:  Genitourin Med       Date:  1997-12

4.  Etiology of genital ulcer disease in Dakar, Senegal, and comparison of PCR and serologic assays for detection of Haemophilus ducreyi.

Authors:  P A Totten; J M Kuypers; C Y Chen; M J Alfa; L M Parsons; S M Dutro; S A Morse; N B Kiviat
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

5.  HIV-1 and other sexually transmitted infections in a cohort of female sex workers in Chiang Rai, Thailand.

Authors:  K Limpakarnjanarat; T D Mastro; S Saisorn; W Uthaivoravit; J Kaewkungwal; S Korattana; N L Young; S A Morse; D S Schmid; B G Weniger; P Nieburg
Journal:  Sex Transm Infect       Date:  1999-02       Impact factor: 3.519

6.  Seroprevalence and incidence of genital ulcer infections in a rural Ugandan population.

Authors:  A Kamali; A J Nunn; D W Mulder; E Van Dyck; J G Dobbins; J A Whitworth
Journal:  Sex Transm Infect       Date:  1999-04       Impact factor: 3.519

7.  The conserved 18,000-molecular-weight outer membrane protein of Haemophilus ducreyi has homology to PAL.

Authors:  S M Spinola; T J Hiltke; K Fortney; K L Shanks
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

Review 8.  Chancroid and Haemophilus ducreyi: an update.

Authors:  D L Trees; S A Morse
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

9.  Inducible immunity with a pilus preparation booster vaccination in an animal model of Haemophilus ducreyi infection and disease.

Authors:  M Desjardins; L G Filion; S Robertson; D W Cameron
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

10.  In vitro stimulation of peripheral blood mononuclear cells (PBMC) from HIV- and HIV+ chancroid patients by Haemophilus ducreyi antigens.

Authors:  L Van Laer; J Vingerhoets; G Vanham; L Kestens; J Bwayo; J Otido; P Piot; E Roggen
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.